Cargando…

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Canada has a long tradition of leading practice-changing clinical trials in oncology. Here, we describe methodology, results, and interpretation of oncology RCTs with Canadian involvement compared to RCTs from other high-income countries (HICs). A literature search identified all RCTs evaluating ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Shubham, Wells, J. Connor, Hopman, Wilma M., Del Paggio, Joseph C., Gyawali, Bishal, Hammad, Nazik, Hay, Annette E., Booth, Christopher M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167552/ https://www.ncbi.nlm.nih.gov/pubmed/33924380 http://dx.doi.org/10.3390/curroncol28020143

Ejemplares similares

Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity
por: Wells, J. Connor, et al.
Publicado: (2022)

Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity
por: Sengar, Manju, et al.
Publicado: (2023)

Participation of Lower and Upper Middle–Income Countries in Clinical Trials Led by High-Income Countries
por: Rubagumya, Fidel, et al.
Publicado: (2022)

Gender differences in outcomes of cancer patients with COVID: Signal or noise?
por: Wijeratne, Don Thiwanka, et al.
Publicado: (2020)

The OlympiAD trial: who won the gold?
por: Gyawali, Bishal
Publicado: (2017)

Intention to probe into the colonoscopy trial: Is it the procedure or the trial that failed?
por: Knopf, Kevin B., et al.
Publicado: (2022)

Objective response rate of placebo in randomized controlled trials of anticancer medicines
por: Sachdev, Arushi, et al.
Publicado: (2022)

Low-value practices in oncology contributing to financial toxicity
por: Gyawali, Bishal
Publicado: (2017)

Assessment of Price and Clinical Benefit of Cancer Drugs in Canada, 2011-2020
por: Jenei, Kristina, et al.
Publicado: (2023)

Negative trials in ovarian cancer: is there such a thing as too much optimism?
por: Gyawali, Bishal, et al.
Publicado: (2016)

Training of oncologists: results of a global survey
por: Jalan, Divyanshi, et al.
Publicado: (2020)

Endpoints used in phase III randomized controlled trials of treatment options for COVID-19
por: Desai, Aakash, et al.
Publicado: (2020)

Overview of Delivery of Cancer Care in Nepal: Current Status and Future Priorities
por: Gyawali, Bishal, et al.
Publicado: (2020)

Clinical Trial End Points in Severe COVID-19
por: Desai, Aakash, et al.
Publicado: (2020)

Delivery of Global Cancer Care: An International Study of Medical Oncology Workload
por: Fundytus, Adam, et al.
Publicado: (2017)

Determinants of a healthy lifestyle and use of preventive screening in Canada
por: Qi, Vikky, et al.
Publicado: (2006)

Community-based intervention for management of diabetes in Nepal (COBIN-D trial): study protocol for a cluster-randomized controlled trial
por: Gyawali, Bishal, et al.
Publicado: (2018)

Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: A meta-analysis of randomized controlled trials
por: Effing, Sophie Marie Anne, et al.
Publicado: (2020)

Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study
por: Gyawali, Bishal, et al.
Publicado: (2021)

Cancer care workforce in Africa: perspectives from a global survey
por: Vanderpuye, Verna, et al.
Publicado: (2019)

Targeting the value of targeted therapy
por: Paggio, Joseph C. Del, et al.
Publicado: (2017)

Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis
por: Addeo, Alfredo, et al.
Publicado: (2019)

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs
por: Gyawali, Bishal, et al.
Publicado: (2021)

Advancing Our Understanding of Dental Care Pathways of Refugees and Asylum Seekers in Canada: A Qualitative Study
por: Nurelhuda, Nazik M., et al.
Publicado: (2021)

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
por: Fundytus, Adam, et al.
Publicado: (2021)

Our Canada Edition
Publicado: (1898)

Risk and benefit for umbrella trials in oncology: a systematic review and meta-analysis
por: Strzebonska, Karolina, et al.
Publicado: (2022)

Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs: A Systematic Review and Pooled Analysis
por: Gyawali, Bishal, et al.
Publicado: (2019)

A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer
por: Gyawali, Bishal, et al.
Publicado: (2021)

Training General Practitioners in Oncology: Lessons Learned From a Cross-Sectional Survey of GPOs in Canada
por: Gyawali, Bishal, et al.
Publicado: (2023)

Cancer drugs in LMICs: cheap but unaffordable
por: Gyawali, Bishal
Publicado: (2017)

Me, Too
por: Gyawali, Bishal
Publicado: (2016)

Letter to Editor-response: placebo response rates
por: Gyawali, Bishal
Publicado: (2023)

Engaging Patients for Clinical Trials in Africa: Patient-Centered Approaches
por: Mutebi, Miriam, et al.
Publicado: (2020)

Effectiveness of a Female Community Health Volunteer–Delivered Intervention in Reducing Blood Glucose Among Adults With Type 2 Diabetes: An Open-Label, Cluster Randomized Clinical Trial
por: Gyawali, Bishal, et al.
Publicado: (2021)

TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib
por: Poudyal, Bishesh Sharma, et al.
Publicado: (2016)

Cheaper Options in the Prevention of Chemotherapy-Induced Nausea and Vomiting
por: Gyawali, Bishal, et al.
Publicado: (2016)

Rapidly established telehealth care for blood cancer patients in Nepal during the COVID-19 pandemic using the free app Viber
por: Poudyal, Bishesh Sharma, et al.
Publicado: (2020)

Innovative Use of mHealth and Clinical Technology for Oncology Clinical Trials in Africa
por: Mutebi, Miriam, et al.
Publicado: (2020)

Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
por: Naci, Huseyin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g7ku14dk8jvi3eu5jmh2956fmq